320 related articles for article (PubMed ID: 32662814)
21. Revealing the therapeutic targets and molecular mechanisms of emodin-treated coronavirus disease 2019 via a systematic study of network pharmacology.
Du HX; Zhu JQ; Chen J; Zhou HF; Yang JH; Wan HT
Aging (Albany NY); 2021 Jun; 13(11):14571-14589. PubMed ID: 34088885
[TBL] [Abstract][Full Text] [Related]
22. Chemical composition and pharmacological mechanism of shenfu decoction in the treatment of novel coronavirus
Li X; Lin H; Wang Q; Cui L; Luo H; Luo L
Drug Dev Ind Pharm; 2020 Dec; 46(12):1947-1959. PubMed ID: 33054436
[TBL] [Abstract][Full Text] [Related]
23. Clinical characterization and therapeutic targets of vitamin A in patients with hepatocholangiocarcinoma and coronavirus disease.
Liang X; Zhou R; Li Y; Yang L; Su M; Lai KP
Aging (Albany NY); 2021 Jun; 13(12):15785-15800. PubMed ID: 34176789
[TBL] [Abstract][Full Text] [Related]
24. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
25. Glycyrrhetinic acid: A potential drug for the treatment of COVID-19 cytokine storm.
Li H; You J; Yang X; Wei Y; Zheng L; Zhao Y; Huang Y; Jin Z; Yi C
Phytomedicine; 2022 Jul; 102():154153. PubMed ID: 35636166
[TBL] [Abstract][Full Text] [Related]
26. Revealing the targets and mechanisms of vitamin A in the treatment of COVID-19.
Li R; Wu K; Li Y; Liang X; Tse WKF; Yang L; Lai KP
Aging (Albany NY); 2020 Aug; 12(15):15784-15796. PubMed ID: 32805728
[TBL] [Abstract][Full Text] [Related]
27. Glycyrrhizic acid prevents ultraviolet-B-induced photodamage: a role for mitogen-activated protein kinases, nuclear factor kappa B and mitochondrial apoptotic pathway.
Afnan Q; Kaiser PJ; Rafiq RA; Nazir LA; Bhushan S; Bhardwaj SC; Sandhir R; Tasduq SA
Exp Dermatol; 2016 Jun; 25(6):440-6. PubMed ID: 26836460
[TBL] [Abstract][Full Text] [Related]
28. Phillyrin for COVID-19 and Influenza Co-infection: A Potential Therapeutic Strategy Targeting Host Based on Bioinformatics Analysis.
Lai Y; Han T; Lao Z; Li G; Xiao J; Liu X
Front Pharmacol; 2021; 12():754241. PubMed ID: 34803696
[No Abstract] [Full Text] [Related]
29. Identification of phytochemical compounds of
Zhang M; Zhang X; Pei J; Guo B; Zhang G; Li M; Huang L
Heliyon; 2023 Mar; 9(3):e14029. PubMed ID: 36911881
[TBL] [Abstract][Full Text] [Related]
30. Based on network pharmacology and bioinformatics to analyze the mechanism of action of Astragalus membranaceus in the treatment of vitiligo and COVID-19.
Wang Y; Ding M; Chi J; Wang T; Zhang Y; Li Z; Li Q
Sci Rep; 2023 Mar; 13(1):3884. PubMed ID: 36890149
[TBL] [Abstract][Full Text] [Related]
31. A Practical Strategy for Exploring the Pharmacological Mechanism of Luteolin Against COVID-19/Asthma Comorbidity: Findings of System Pharmacology and Bioinformatics Analysis.
Xie YZ; Peng CW; Su ZQ; Huang HT; Liu XH; Zhan SF; Huang XF
Front Immunol; 2021; 12():769011. PubMed ID: 35069542
[TBL] [Abstract][Full Text] [Related]
32. Glycyrrhizic Acid Nanoparticles as Antiviral and Anti-inflammatory Agents for COVID-19 Treatment.
Zhao Z; Xiao Y; Xu L; Liu Y; Jiang G; Wang W; Li B; Zhu T; Tan Q; Tang L; Zhou H; Huang X; Shan H
ACS Appl Mater Interfaces; 2021 May; 13(18):20995-21006. PubMed ID: 33930273
[TBL] [Abstract][Full Text] [Related]
33. Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.
Zhang W; Yang Z; Zhou F; Wei Y; Ma X
Front Endocrinol (Lausanne); 2022; 13():935906. PubMed ID: 36157452
[TBL] [Abstract][Full Text] [Related]
34. Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology.
Zheng WJ; Yan Q; Ni YS; Zhan SF; Yang LL; Zhuang HF; Liu XH; Jiang Y
BioData Min; 2020; 13():17. PubMed ID: 33082858
[TBL] [Abstract][Full Text] [Related]
35. Glycyrrhizic acid alleviates liver fibrosis in vitro and in vivo via activating CUGBP1-mediated IFN-γ/STAT1/Smad7 pathway.
Guo M; Wang Z; Dai J; Fan H; Yuan N; Gao L; Peng H; Cheng X
Phytomedicine; 2023 Apr; 112():154587. PubMed ID: 36805480
[TBL] [Abstract][Full Text] [Related]
36. Functional benefit and molecular mechanism of vitamin C against perfluorooctanesulfonate-associated leukemia.
Li R; Guo C; Li Y; Liang X; Su M
Chemosphere; 2021 Jan; 263():128242. PubMed ID: 33297189
[TBL] [Abstract][Full Text] [Related]
37. Glycyrrhizic Acid Attenuates the Inflammatory Response After Spinal Cord Injury by Inhibiting High Mobility Group Box-1 Protein Through the p38/Jun N-Terminal Kinase Signaling Pathway.
Wu Z; Wang Z; Xie Z; Zhu H; Li C; Xie S; Zhou W; Zhang Z; Li M
World Neurosurg; 2022 Feb; 158():e856-e864. PubMed ID: 34838764
[TBL] [Abstract][Full Text] [Related]
38. Exploring the possible molecular targeting mechanism of Saussurea involucrata in the treatment of COVID-19 based on bioinformatics and network pharmacology.
Zhang D; Wang Z; Li J; Zhu J
Comput Biol Med; 2022 Jul; 146():105549. PubMed ID: 35751193
[TBL] [Abstract][Full Text] [Related]
39. Protection of glycyrrhizic acid against AGEs-induced endothelial dysfunction through inhibiting RAGE/NF-κB pathway activation in human umbilical vein endothelial cells.
Feng L; Zhu MM; Zhang MH; Wang RS; Tan XB; Song J; Ding SM; Jia XB; Hu SY
J Ethnopharmacol; 2013 Jun; 148(1):27-36. PubMed ID: 23528363
[TBL] [Abstract][Full Text] [Related]
40. Glycyrrhizic acid pretreatment prevents sepsis-induced acute kidney injury via suppressing inflammation, apoptosis and oxidative stress.
Zhao H; Liu Z; Shen H; Jin S; Zhang S
Eur J Pharmacol; 2016 Jun; 781():92-9. PubMed ID: 27063444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
